- Pharmaceutical Outsourcing Interview:
An interview with ResearchDx in Pharmaceutical Outsourcing
- Frost and Sullivan Award:
ResearchDx is the proud recipient of the prestigious Frost and Sullivan Award for Outstanding Performance in the Companion Diagnostics Sector
F&S Press Release
- Next Generation Sequencing Services:
ResearchDx now offers Next Generation Sequencing (NGS) services in our CLIA and clinical research divisions.
Whole Genome Sequencing
- ResearchDx at Next Generation Dx 2013:
Tara Kochis spoke with Principal and Co-Founder Philip Cotter at Next Generation Dx about ResearchDx and its services.
Watch them here
- 2013 Biopharma India:
ResearchDx proudly sponsors and presents at BioPharma India.
- Strategic Partnership Award:
ResearchDx, the leading Contract Diagnostics Organization, receives a Strategic Partner Award from WuXi AppTec
Read the press release
ResearchDx is the leading Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. We provide integrated, turn-key, flexible services that are focused on our customers’ objectives. We manage the entire diagnostic development process – from initial assay concept and discovery through clinical research to regulatory approval. At ResearchDx, we take contract R&D for diagnostics to the next generation.
Trust ResearchDx to stay on track
ResearchDx provides independent and unbiased guidance, expert analysis and seamless integration of all the services you need to develop a diagnostic product including; assay development, clinical laboratory services, clinical trial design and conduct, project management, manufacturing, regulatory guidance and submissions, and consulting
ResearchDx can adapt to meet your complex and constantly evolving needs for diagnostic development. We can build, validate, and perform any assay that your business demands, or alternatively work with competing technology vendors to ensure the best fit for your application.
Your diagnostic development is ResearchDx’s sole focus. We have the experience and dedication to ensure the fastest possible path to commercialization and regulatory approval of the diagnostic product.